<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="synergistically through human immune responses. We examine dengue incidence from" exact="Brazil" post="and Colombia before, during, and after the Zika epidemic."/>
 <result pre="human immune responses. We examine dengue incidence from Brazil and" exact="Colombia" post="before, during, and after the Zika epidemic. We find"/>
 <result pre="show that dengue incidence was unusually low in 2017 in" exact="Brazil" post="and Colombia, and simulations incorporating immune-mediated interactions predict reductions"/>
 <result pre="other circulating pathogens. ZIKV was identified in the Americas in" exact="Brazil" post="in late 201517, though phylogeographic analyses suggest ZIKV may"/>
 <result pre="ZIKV may have arrived as early as mid-201318, entering northeast" exact="Brazil" post="in early 201419. The outbreak in the Americas was"/>
 <result pre="intensified surveillance and control efforts. Since 2016, Zika incidence in" exact="Brazil" post="has dropped precipitously, from over 200,000 probable cases in"/>
 <result pre="200,000 probable cases in 2016 to 18,548 in 201725. In" exact="Colombia" post="incidence dropped from approximately 90,000 in 2016 to 1641"/>
 <result pre="for enhancement4–7 and for cross-protection5,7–10. Here, we examine data from" exact="Brazil" post="(1999–2017)25,33,34 and Colombia (2007–2017)25,35,36 to determine whether dengue incidence"/>
 <result pre="for cross-protection5,7–10. Here, we examine data from Brazil (1999–2017)25,33,34 and" exact="Colombia" post="(2007–2017)25,35,36 to determine whether dengue incidence has been atypical"/>
 <result pre="time series of probable case counts for each state in" exact="Brazil" post="(1999–2017)25,33,34 and department in Colombia (2007–2017)25,35,36 (see &quot;Methods�?, Fig."/>
 <result pre="counts for each state in Brazil (1999–2017)25,33,34 and department in" exact="Colombia" post="(2007–2017)25,35,36 (see &quot;Methods�?, Fig. 1b, d, Supplementary Fig. 1)."/>
 <result pre="(see &quot;Methods�?, Fig. 1b, d, Supplementary Fig. 1). In 2017," exact="Brazil" post="had the lowest annual incidence rate (IR) of dengue"/>
 <result pre="incidence rate (IR) of dengue since 2005 (Fig. 1a) and" exact="Colombia" post="had the lowest annual dengue incidence since 2007 (the"/>
 <result pre="available data) (Fig. 1c). Fig. 1 Estimated dengue incidence in" exact="Brazil" post="and Colombia (per 100,000). Note that Zika incidence was"/>
 <result pre="(Fig. 1c). Fig. 1 Estimated dengue incidence in Brazil and" exact="Colombia" post="(per 100,000). Note that Zika incidence was not systematically"/>
 <result pre="Zika incidence was not systematically reported prior to 2016 in" exact="Brazil" post="(a) or late 2015 in Colombia (c) and that"/>
 <result pre="prior to 2016 in Brazil (a) or late 2015 in" exact="Colombia" post="(c) and that Chikungunya was not systematically reported prior"/>
 <result pre="systematically reported prior to 2015 and late 2014 respectively in" exact="Brazil" post="(a) and Colombia (c). In Brazil, updated data from"/>
 <result pre="to 2015 and late 2014 respectively in Brazil (a) and" exact="Colombia" post="(c). In Brazil, updated data from the following year’s"/>
 <result pre="for 2014 to Epiweek 42, 2017 is used. States in" exact="Brazil" post="(b) and departments in Colombia (d) are arranged by"/>
 <result pre="2017 is used. States in Brazil (b) and departments in" exact="Colombia" post="(d) are arranged by region and then by latitude"/>
 <result pre="atypically large incidence occurred significantly more often than expected in" exact="Brazil" post="in 2015 (Fig. 2a, b). In 2017, Brazil experienced"/>
 <result pre="expected in Brazil in 2015 (Fig. 2a, b). In 2017," exact="Brazil" post="experienced an increase in both atypically high and atypically"/>
 <result pre="and observed dengue incidence. Results for 2014–2017 are shown for" exact="Brazil" post="(a, b) and Colombia (c, d) (see Supplementary Fig."/>
 <result pre="Results for 2014–2017 are shown for Brazil (a, b) and" exact="Colombia" post="(c, d) (see Supplementary Fig. 5 and 6 for"/>
 <result pre="than that of corresponding biweeks in other years in both" exact="Brazil" post="(mean: 2.21-fold increase, 95% CrI: 1.45–3.37) and Colombia (mean:"/>
 <result pre="in both Brazil (mean: 2.21-fold increase, 95% CrI: 1.45–3.37) and" exact="Colombia" post="(mean: 1.11-fold increase, 95% CrI: 0.96–1.29). In contrast, we"/>
 <result pre="that biweekly dengue incidence in 2017 was lower in both" exact="Brazil" post="(relative incidence mean: 0.63, 95% CrI: 0.46–0.86) and Colombia"/>
 <result pre="both Brazil (relative incidence mean: 0.63, 95% CrI: 0.46–0.86) and" exact="Colombia" post="(relative incidence mean: 0.23, 95% CrI: 0.18–0.29). At the"/>
 <result pre="year model are highlighted in yellow. Shared effect coefficients for" exact="Brazil" post="(a) and Colombia (c). Zika and chikungunya coefficients are"/>
 <result pre="highlighted in yellow. Shared effect coefficients for Brazil (a) and" exact="Colombia" post="(c). Zika and chikungunya coefficients are estimated from autoregressive"/>
 <result pre="Shared year multipliers for expected dengue incidence are shown for" exact="Brazil" post="(b) and Colombia (d). The top row of panels"/>
 <result pre="for expected dengue incidence are shown for Brazil (b) and" exact="Colombia" post="(d). The top row of panels b and d"/>
 <result pre="the previous biweek’s Zika incidence and dengue transmission potential in" exact="Brazil" post="(mean coefficient: 0.16, 95% CrI: 0.05–0.26, Fig. 3a). Putting"/>
 <result pre="association between cumulative Zika incidence on dengue transmission potential in" exact="Brazil" post="(mean coefficient: 0.04, 95% CrI: 0.003, 0.08). No significant"/>
 <result pre="DENV and ZIKV could produce the dengue dynamics observed in" exact="Brazil" post="and Colombia by simulating the arrival of Zika in"/>
 <result pre="ZIKV could produce the dengue dynamics observed in Brazil and" exact="Colombia" post="by simulating the arrival of Zika in a dengue"/>
 <result pre="3a and c) indicate a reduction in dengue incidence in" exact="Brazil" post="and Colombia. Utilizing available Zika case data, we were"/>
 <result pre="between cumulative Zika cases and observed dengue incidence. In both" exact="Brazil" post="and Colombia, misclassified cases (potentially resulting from shared symptoms"/>
 <result pre="demonstrate a significant decline in dengue cases in 2017 in" exact="Brazil" post="and Colombia. Studies involving laboratory confirmed cases and enhanced"/>
 <result pre="levels. Atypically low dengue case counts observed in 2017 in" exact="Brazil" post="and Colombia suggest that population-level susceptibility to symptomatic dengue"/>
 <result pre="low dengue case counts observed in 2017 in Brazil and" exact="Colombia" post="suggest that population-level susceptibility to symptomatic dengue has been"/>
 <result pre="dengue epidemics in upcoming seasons. As of August, 2019, both" exact="Brazil" post="and Colombia have reported more cases at this point"/>
 <result pre="in upcoming seasons. As of August, 2019, both Brazil and" exact="Colombia" post="have reported more cases at this point in the"/>
 <result pre="in recent years. Methods Data sources We collated data from" exact="Brazil" post="(27 states) and Colombia (32 departments) into a public"/>
 <result pre="Data sources We collated data from Brazil (27 states) and" exact="Colombia" post="(32 departments) into a public data repository25. For Brazil,"/>
 <result pre="the Secretariat of Health Surveillance in the Ministry of Health," exact="Brazil" post="where the number of probable cases, severe dengue, dengue"/>
 <result pre="the primary and secondary entries. The Epidemiological Bulletins published in" exact="Brazil" post="for 2014–2017 also report the corresponding dengue data for"/>
 <result pre="and other central nervous system disorders in newborns40 reported in" exact="Brazil" post="since Epiweek 45, 2015 through the end of 2016."/>
 <result pre="reported in the 2016 Epiweek 1 bulletin. In the updated" exact="Colombia" post="dataset, the first documented Zika cases were in 2015"/>
 <result pre="We also gathered subnational level population size data for both" exact="Brazil" post="and Colombia25 from the Instituto Brasileiro de Geografia e"/>
 <result pre="dengue, Zika, and chikungunya case counts for each state in" exact="Brazil" post="and department in Colombia. The Epidemiological Bulletins provide estimates"/>
 <result pre="the construction of all case count time series for both" exact="Brazil" post="and Colombia. For Brazil, we use the final (updated"/>
 <result pre="available. When performing our analysis, we used updated data for" exact="Brazil" post="up through Epiweek 42, 2017 (since updated data for"/>
 <result pre="greatest numbers of cases in each subnational location (states in" exact="Brazil" post="and departments in Colombia). In Brazil, dengue seasons were"/>
 <result pre="autoregressive model43 with negative binomial errors for each state in" exact="Brazil" post="and each department in Colombia using incidence data from"/>
 <result pre="errors for each state in Brazil and each department in" exact="Colombia" post="using incidence data from that location in all other"/>
 <result pre="we did not include 1999 in the permutation test for" exact="Brazil" post="since data is not available for the entire year"/>
 <result pre="dataset is in August 1999). Hierarchical regression models Separately for" exact="Brazil" post="and Colombia, we fit a set of spatial hierarchical"/>
 <result pre="spatial hierarchical models for dengue incidence (using state-level data for" exact="Brazil" post="models and department-level data for Colombia models) with negative"/>
 <result pre="(using state-level data for Brazil models and department-level data for" exact="Colombia" post="models) with negative binomial errors. We considered models with"/>
 <result pre="Outbreak, Bahia, BrazilEmerg. Infect. Dis.2015211885188610.3201/eid2110.15084726401719 18.LednickyJet al.Zika Virus Outbreak in" exact="Haiti" post="in 2014: Molecular and Clinical DataPLoS Negl. Trop. Dis.201610e000468710.1371/journal.pntd.000468727111294"/>
 <result pre="Dis.201610e000468710.1371/journal.pntd.000468727111294 19.FariaNRet al.Establishment and cryptic transmission of Zika virus in" exact="Brazil" post="and the AmericasNature201754640641010.1038/nature2240128538727 20.World Health Organization. Situation Report-Zika virus,"/>
 <result pre="M. et al. High Zika Virus Seroprevalence in Salvador, Northeastern" exact="Brazil" post="limits the potential for further outbreaks. MBio8, e01390-17 (2017)."/>
 <result pre="States of MicronesiaN. Engl. J. Med.20093602536254310.1056/NEJMoa080571519516034 24.AubryMet al.Zika Virus Seroprevalence," exact="French Polynesia," post="2014–2015Emerg. Infect. Dis.20172366967210.3201/eid2304.16154928084987 25.Borchering, R. K. et al. UF-IDD/dengue-Zika-chik_Americas"/>
 <result pre="26.RobbianiDFet al.Recurrent potent human neutralizing antibodies to Zika virus in" exact="Brazil" post="and MexicoCell2017169597609.e1110.1016/j.cell.2017.04.02428475892 27.SapparapuGet al.Neutralizing human antibodies prevent Zika virus"/>
</results>
